CEO Dave Ricks said Friday that the company will make its planned GLP-1 weight-loss pill in the U.S. amid President Donald ...

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

Wellness coach Rachael Sacerdoti shares her advice for women in midlife coming off Ozempic, Mounjaro and other weight loss ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...